HOME
TEAM
INVESTOR RELATIONS
CONTACT
More
10/1/24
TenX Keane Acquisition Announces Contribution to Trust Account in Connection with Extension Amendment Proposal
24/10/23
Citius Pharmaceuticals Executes Definitive Agreement to Merge Wholly Owned Subsidiary with TenX Keane Acquisition to Form Publicly Listed Citius Oncology, Inc.
18/10/23
TenX Keane Acquisition Announces Extension of the Deadline for an Initial Business Combination
All filings for TenX Keane Acquisition available via EDGAR.